Recent studies showed that KDM4C, in cooperation with PRMT1, remodeled epigenetic programs and deregulated transcriptional patterns by removing the repressive effect of H3K9me3 on HOXA9, and could maintain the survival of AML [13]. This evidence concerns the gene KDM4C and acute myeloid leukemia.